PGNX - Progenics Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5625.87M
Enterprise Value 3607.67M
Trailing P/E N/A
Forward P/E 1-94.33
PEG Ratio (5 yr expected) 1-0.05
Price/Sales (ttm)49.91
Price/Book (mrq)10.19
Enterprise Value/Revenue 348.46
Enterprise Value/EBITDA 6-11.48

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Mar 31, 2018

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-431.14%

Management Effectiveness

Return on Assets (ttm)-20.89%
Return on Equity (ttm)-64.16%

Income Statement

Revenue (ttm)12.54M
Revenue Per Share (ttm)0.18
Quarterly Revenue Growth (yoy)35.90%
Gross Profit (ttm)11.7M
EBITDA -52.91M
Net Income Avi to Common (ttm)-48.08M
Diluted EPS (ttm)-0.68
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)83.43M
Total Cash Per Share (mrq)1.13
Total Debt (mrq)49.75M
Total Debt/Equity (mrq)82.07
Current Ratio (mrq)6.45
Book Value Per Share (mrq)0.83

Cash Flow Statement

Operating Cash Flow (ttm)-55.14M
Levered Free Cash Flow (ttm)-38.2M

Trading Information

Stock Price History

Beta 2.69
52-Week Change 313.69%
S&P500 52-Week Change 312.74%
52 Week High 39.12
52 Week Low 34.60
50-Day Moving Average 37.98
200-Day Moving Average 36.95

Share Statistics

Avg Vol (3 month) 31.11M
Avg Vol (10 day) 31.41M
Shares Outstanding 573.72M
Float 69.53M
% Held by Insiders 10.59%
% Held by Institutions 184.37%
Shares Short 39.87M
Short Ratio 39.5
Short % of Float 318.85%
Shares Short (prior month) 39.94M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A